TEXAS ORTHOPEDIC HOSPITA — History
CCN 450804 | 3-year financial timeline | COVID resilience: 57/100
🛡️ Public data only — no PHI permitted on this instance.
$238M
Latest Revenue (FY2022)
+11.8%
Revenue CAGR (3yr)
46.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $190M | $215M | $238M | +10.6% | +11.8% |
| Operating Expenses | $102M | $120M | $128M | +6.1% | +11.7% |
| Operating Margin | 46.2% | 44.0% | 46.3% | +5.2% | +0.1% |
| Net Income | $88M | $95M | $110M | +16.3% | +12.0% |
| Licensed Beds | 49 | 49 | 42 | -14.3% | -7.4% |
| Total Patient Days | 6,254 | 6,677 | 6,339 | -5.1% | +0.7% |
| Medicare Day % | 37% | 35% | 36% | +1.9% | -0.7% |
| Medicaid Day % | 0% | 0% | nan% | +nan% | +nan% |
COVID Impact & Recovery
Resilience Score: 57/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +25.1% ($190M → $238M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▶ Stable
Beds▼ Declining
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+11.8%
This Hospital
+7.6%
State Avg
Latest Margin
46.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $262M | 46.4% |
| FY2024 (proj) | $286M | 46.4% |
| FY2025 (proj) | $309M | 46.5% |